A compliance restoration implant device includes a first compliant fluid container, a second compliant fluid container, and a conduit structure. The first compliant fluid container includes a first lumen that widens in response to fluid leaving the first compliant fluid container and narrows in response to the fluid entering the first compliant fluid container. The second compliant fluid container includes a second lumen that widens in response to the fluid leaving the second compliant fluid container and narrows in response to the fluid entering the second compliant fluid container. The conduit structure is coupled to the first compliant fluid container and the second compliant fluid container and is configured to pass fluid between the first compliant fluid container and the second compliant fluid container in response to changing pressure levels outside one of the fluid containers.

A compliance restoration implant device includes a first compliant fluid container, a second compliant fluid container, and a conduit structure. The first compliant fluid container includes a first lumen that widens in response to fluid leaving the first compliant fluid container and narrows in response to the fluid entering the first compliant fluid container. The second compliant fluid container includes a second lumen that widens in response to the fluid leaving the second compliant fluid container and narrows in response to the fluid entering the second compliant fluid container. The conduit structure is coupled to the first compliant fluid container and the second compliant fluid container and is configured to pass fluid between the first compliant fluid container and the second compliant fluid container in response to changing pressure levels outside one of the fluid containers.

The present invention relates to a medical chamber system (700) for implantation in the chest of a patient to support the heart activity, preferably by displacing the heart apex (105), comprising at least a first chamber (702) for arrangement inside the heart sac (300) and a second chamber (701) for arrangement outside the heart sac (300), wherein the chambers (701, 702) comprise at least one connection portion or connection channel (703) which connects the two chambers (701, 702) to each other, the chambers (701, 702) and the connection channel (703) are further embodied to be filled with fluid (705) and, preferably in the implanted state, to be arranged such that the heart activity acts on the first chamber (702) and that the second chamber (701) acts as a volume storage and/or energy storage for the fluid (705). Furthermore, the present invention relates to an introduction system for a medical chamber system (700) and to a kit, encompassing a medical chamber system (700) and an introduction system.

The present invention relates to a medical chamber system (700) for implantation in the chest of a patient to support the heart activity, preferably by displacing the heart apex (105), comprising at least a first chamber (702) for arrangement inside the heart sac (300) and a second chamber (701) for arrangement outside the heart sac (300), wherein the chambers (701, 702) comprise at least one connection portion or connection channel (703) which connects the two chambers (701, 702) to each other, the chambers (701, 702) and the connection channel (703) are further embodied to be filled with fluid (705) and, preferably in the implanted state, to be arranged such that the heart activity acts on the first chamber (702) and that the second chamber (701) acts as a volume storage and/or energy storage for the fluid (705). Furthermore, the present invention relates to an introduction system for a medical chamber system (700) and to a kit, encompassing a medical chamber system (700) and an introduction system.

A method of operating a counterpulsation device (CPD) in a human or animal subject is disclosed, the method including: receiving a heart beat signal indicative of the heart beat of the subject; providing counterpulsation therapy by controlling the pressure supplied to a CPD drive line in pneumatic communication with the CPD to cause the CPD to alternately fill with blood and eject blood with a timing that is determined at least in part based on the heart beat signal; while providing counterpulsation therapy, receiving a CPD drive line pressure signal indicative of the pressure in the CPD drive line; and adjusting the pressure supplied to the drive line based at least in part on the drive line pressure signal.

A method of operating a counterpulsation device (CPD) in a human or animal subject is disclosed, the method including: receiving a heart beat signal indicative of the heart beat of the subject; providing counterpulsation therapy by controlling the pressure supplied to a CPD drive line in pneumatic communication with the CPD to cause the CPD to alternately fill with blood and eject blood with a timing that is determined at least in part based on the heart beat signal; while providing counterpulsation therapy, receiving a CPD drive line pressure signal indicative of the pressure in the CPD drive line; and adjusting the pressure supplied to the drive line based at least in part on the drive line pressure signal.

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.